Cargando…

Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores

OBJECTIVE: To develop and validate a composite rheumatoid arthritis (RA) disease activity index using optical spectral transmission (OST) scores obtained with the HandScan, replacing tender and swollen joint counts. METHODS: RA patients from a single center routinely undergoing HandScan measurements...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, Maxime M. A., Westgeest, Antonius A. A., Schwarting, Andreas, Jacobs, Johannes W. G., Heller, Caroline, van Laar, Jacob M., Lafeber, Floris P. J. G., Tekstra, Janneke, Triantafyllias, Konstantinos, Welsing, Paco M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540315/
https://www.ncbi.nlm.nih.gov/pubmed/33770421
http://dx.doi.org/10.1002/acr.24607
_version_ 1784803683930734592
author Verhoeven, Maxime M. A.
Westgeest, Antonius A. A.
Schwarting, Andreas
Jacobs, Johannes W. G.
Heller, Caroline
van Laar, Jacob M.
Lafeber, Floris P. J. G.
Tekstra, Janneke
Triantafyllias, Konstantinos
Welsing, Paco M. J.
author_facet Verhoeven, Maxime M. A.
Westgeest, Antonius A. A.
Schwarting, Andreas
Jacobs, Johannes W. G.
Heller, Caroline
van Laar, Jacob M.
Lafeber, Floris P. J. G.
Tekstra, Janneke
Triantafyllias, Konstantinos
Welsing, Paco M. J.
author_sort Verhoeven, Maxime M. A.
collection PubMed
description OBJECTIVE: To develop and validate a composite rheumatoid arthritis (RA) disease activity index using optical spectral transmission (OST) scores obtained with the HandScan, replacing tender and swollen joint counts. METHODS: RA patients from a single center routinely undergoing HandScan measurements with at least 1 concurrent OST score and Disease Activity Score in 28 joints (DAS28) were included. Data were extracted from medical records. Linear regression analyses with the DAS28 as the outcome were performed to create a disease activity index (DAS‐OST). OST score, erythrocyte sedimentation rate (ESR), and patient global assessment (PtGA) visual analog scale (VAS), sex, age, disease duration, and rheumatoid factor status were evaluated as independent variables. Final models were derived based on the statistical significance of coefficients and model fit. Of the data, two‐thirds were used for development and one‐third for validation; external validation was performed in a cohort from another center. Agreement between DAS‐OST and DAS28 was assessed using the Bland‐Altman plot method and intraclass correlation coefficient (ICC). Diagnostic value of the DAS‐OST was determined for established definitions of remission, low disease activity (LDA), and high disease activity (HDA). RESULTS: Data of 3,358 observations from 1,505 unique RA patients were extracted. DAS‐OST was defined as: –0.44 + OST × 0.03 + male × –0.11 + LN(ESR) × 0.77 + PtGA VAS × 0.03. The ICCs between DAS‐OST and DAS28 were 0.88 (95% confidence interval [95% CI] 0.87–0.90) and 0.82 (95% CI 0.75–0.86) and measurement errors were 0.58 and 0.87 in internal and external validation, respectively. Sensitivity for remission, LDA, and HDA was 79%, 91%, and 43%, respectively, and specificity was 92%, 80%, and 96% in external validation. CONCLUSION: Using the HandScan, RA disease activity can be accurately estimated if combined with ESR, PtGA VAS, and sex into a disease activity index (DAS‐OST).
format Online
Article
Text
id pubmed-9540315
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95403152022-10-14 Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores Verhoeven, Maxime M. A. Westgeest, Antonius A. A. Schwarting, Andreas Jacobs, Johannes W. G. Heller, Caroline van Laar, Jacob M. Lafeber, Floris P. J. G. Tekstra, Janneke Triantafyllias, Konstantinos Welsing, Paco M. J. Arthritis Care Res (Hoboken) Rheumatoid Arthritis OBJECTIVE: To develop and validate a composite rheumatoid arthritis (RA) disease activity index using optical spectral transmission (OST) scores obtained with the HandScan, replacing tender and swollen joint counts. METHODS: RA patients from a single center routinely undergoing HandScan measurements with at least 1 concurrent OST score and Disease Activity Score in 28 joints (DAS28) were included. Data were extracted from medical records. Linear regression analyses with the DAS28 as the outcome were performed to create a disease activity index (DAS‐OST). OST score, erythrocyte sedimentation rate (ESR), and patient global assessment (PtGA) visual analog scale (VAS), sex, age, disease duration, and rheumatoid factor status were evaluated as independent variables. Final models were derived based on the statistical significance of coefficients and model fit. Of the data, two‐thirds were used for development and one‐third for validation; external validation was performed in a cohort from another center. Agreement between DAS‐OST and DAS28 was assessed using the Bland‐Altman plot method and intraclass correlation coefficient (ICC). Diagnostic value of the DAS‐OST was determined for established definitions of remission, low disease activity (LDA), and high disease activity (HDA). RESULTS: Data of 3,358 observations from 1,505 unique RA patients were extracted. DAS‐OST was defined as: –0.44 + OST × 0.03 + male × –0.11 + LN(ESR) × 0.77 + PtGA VAS × 0.03. The ICCs between DAS‐OST and DAS28 were 0.88 (95% confidence interval [95% CI] 0.87–0.90) and 0.82 (95% CI 0.75–0.86) and measurement errors were 0.58 and 0.87 in internal and external validation, respectively. Sensitivity for remission, LDA, and HDA was 79%, 91%, and 43%, respectively, and specificity was 92%, 80%, and 96% in external validation. CONCLUSION: Using the HandScan, RA disease activity can be accurately estimated if combined with ESR, PtGA VAS, and sex into a disease activity index (DAS‐OST). Wiley Periodicals, Inc. 2022-06-18 2022-09 /pmc/articles/PMC9540315/ /pubmed/33770421 http://dx.doi.org/10.1002/acr.24607 Text en © 2021 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Rheumatoid Arthritis
Verhoeven, Maxime M. A.
Westgeest, Antonius A. A.
Schwarting, Andreas
Jacobs, Johannes W. G.
Heller, Caroline
van Laar, Jacob M.
Lafeber, Floris P. J. G.
Tekstra, Janneke
Triantafyllias, Konstantinos
Welsing, Paco M. J.
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title_full Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title_fullStr Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title_full_unstemmed Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title_short Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores
title_sort development and validation of rheumatoid arthritis disease activity indices including handscan (optical spectral transmission) scores
topic Rheumatoid Arthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540315/
https://www.ncbi.nlm.nih.gov/pubmed/33770421
http://dx.doi.org/10.1002/acr.24607
work_keys_str_mv AT verhoevenmaximema developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT westgeestantoniusaa developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT schwartingandreas developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT jacobsjohanneswg developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT hellercaroline developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT vanlaarjacobm developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT lafeberflorispjg developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT tekstrajanneke developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT triantafylliaskonstantinos developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores
AT welsingpacomj developmentandvalidationofrheumatoidarthritisdiseaseactivityindicesincludinghandscanopticalspectraltransmissionscores